His experience and expertise is unparalleled. Circulation, 134 2, e7-8, Pokorney, Sean D; Piccini, Jonathan P; Stevens, Susanna R; Patel, Manesh R; Pieper, Karen S; Halperin, Jonathan L; Breithardt, Gnter; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2016. Clinical chemistry, 59 9, 1369-75, Becker, Richard C 2013. Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, So Paulo, Brazil. Piccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Breithardt, Gnter; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2015. Pharmacogenomics, 13 5, 533-42, Hankey, Graeme J; Patel, Manesh R; Stevens, Susanna R; Becker, Richard C; Breithardt, Gnter; Carolei, Antonio; Diener, Hans-Christoph; Donnan, Geoffrey A; Halperin, Jonathan L; Mahaffey, Kenneth W; Mas, Jean-Louis; Massaro, Ayrton; Norrving, Bo; Nessel, Christopher C; Paolini, John F; Roine, Risto O; Singer, Daniel E; Wong, Lawrence; Califf, Robert M; Fox, Keith A A; Hacke, Werner 2012. 1303 Mccullough Ave, San Antonio, TX. United for superior care. The Times Colonist. Price, Joshua J; Urbina, Elaine M; Carlin, Kristen; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2022. : 1979), 74 3, 590-596, Ali, Mahboob; Girgis, Sameh; Hassan, Atif; Rudick, Steven; Becker, Richard C 2018. Nancy B. Beck, Richard A. Becker, Neeraja K. Erraguntla, William H. Farland, Roberta L. Grant, George M. Gray, Christopher R. Kirman, Judy S. LaKind, R. Jeffrey Lewis, Patricia Nance, Lynn H. Pottenger, Susan L. Santos, Stephanie Shirley, Ted W. Simon, Michael L. Dourson. Journal of the American College of Cardiology, 57 6, 672-84, Lopes, Renato D; Becker, Richard C; Alexander, John H; Armstrong, Paul W; Califf, Robert M; Chan, Mark Y; Crowther, Mark; Granger, Christopher B; Harrington, Robert A; Hylek, Elaine M; James, Stefan K; Jolicoeur, E Marc; Mahaffey, Kenneth W; Newby, L Kristin; Peterson, Eric D; Pieper, Karen S; Van de Werf, Frans; Wallentin, Lars; White, Harvey D; Carvalho, Antonio C; Giraldez, Roberto R; Guimaraes, Helio P; Nader, Helena B; Kalil, Renato A K; Bizzachi, Joyce M A; Lopes, Antonio C; Garcia, David A 2011. WHO Recommends Surgical Checklist, Cancer Society Calls for Cigarillo Ban . A North-American perspective. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. The unmet need for philanthropic funding of early career cardiovascular investigators. . The study found 38 percent fewer prostate cancer deaths among men randomly assigned to the surgery group versus those in what the Swedes called the watchful-waiting group. : 1979), 72 4, 955-961, Kochar, Ajar; Hellkamp, Anne S; Lokhnygina, Yuliya; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Piccini, Jonathan P; Patel, Manesh R 2018. Toward the Development and Application of an Environmental Risk Assessment Framework for Microplastic. Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept. {C} Regulatory toxicology and pharmacology : RTP, 90 , 185-196, Becker, Richard C 2017. Nature reviews. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease. Background: Preclinical studies showing that pomegranate juice and its components inhibit prostate cancer led to multiple clinical trials to determine whether pomegranate products could slow the growth of prostate cancer. Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future. Medical oncologist Dr. Kevin Becker is part of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical Center. Board Certifications: Hematology, Internal Medicine and Medical Oncology. Cardiology, 8 10, 560-71, Becker, Richard C 2011. Impact of body mass index on markers of left ventricular thickness and mass calculation: results of a pilot analysis. Scientific reports, 10 1, 6169, Becker, Richard C 2020. The American journal of medicine, 129 5 Suppl, S1-S29, Shah, Rohan; Hellkamp, Anne; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Fox, Keith A A; Nessel, Christopher C; Mahaffey, Kenneth W; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2016. Journal of thrombosis and thrombolysis, , Wisler, James W; Becker, Richard C 2014. Hypertension (Dallas, Tex. Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go? Annals of internal medicine, 158 12, 861-8. General Endocrinology + 3 more subspecialties. Hypertension (Dallas, Tex. See all conditions on Dr. Becker's, Best Hospitals for Diabetes & Endocrinology, Lilly Plans to Slash Some Insulin Prices, Expand Cost Cap. Sex differences in mortality following acute coronary syndromes. This activation triggers the responses of adaptive immune cells such as CD4 (+) or CD8 (+) T cells and B cells, resulting in the inhibition of tumor growth and metastasis. Search below to find a doctor with that skillset. Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF. The New England journal of medicine, 381 12, 1169-1170, Becker, Richard C; Cotarlan, Vlad; Sadayappan, Sakthi 2019. These ailments include diabetes, thyroid ailments, metabolic and nutritional disorders, pituitary diseases, menstrual and sexual problems. Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience. 2000 -2011. Lorenz R. Rhomberg, Julie E. Goodman, Lisa A. Bailey, Robyn L. Prueitt, Nancy B. Beck, Christopher Bevan, Michael Honeycutt, Norbert E. Kaminski, Greg Paoli, Lynn H. Pottenger, Roberta W. Scherer, Kimberly Wise, Richard A. Becker, Advancing human health risk assessment: Integrating recent advisory committee recommendations, Michael L. Dourson, Richard A. Becker, Lynne T. Haber, Lynn H. Pottenger, Tiffany Bredfeldt, Penelope A. Fenner-Crisp. Toxicology and applied pharmacology, 387 , 114774, Becker, Kristian C; Kwee, Lydia Coulter; Neely, Megan L; Grass, Elizabeth; Jakubowski, Joseph A; Fox, Keith A A; White, Harvey D; Gregory, Simon G; Gurbel, Paul A; Carvalho, Leonardo de Pinto; Becker, Richard C; Magnus Ohman, E; Roe, Matthew T; Shah, Svati H; Chan, Mark Y 2020. Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? Developing context appropriate toxicity testing approaches using new alternative methods (NAMs). Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians. Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients. View the PDF. JACC. Wallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo A; Mahaffey, Kenneth M; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. American heart journal, 200 , 102-109, DeWald, Tracy A; Washam, Jeffrey B; Becker, Richard C 2018. Annual review of pharmacology and toxicology, 57 , 61-79, Pollack, Charles V; Davoudi, Farideh; Diercks, Deborah B; Becker, Richard C; James, Stefan K; Lim, Soo Teik; Schulte, Phillip J; Spinar, Jindrich; Steg, Philippe Gabriel; Storey, Robert F; Himmelmann, Anders; Wallentin, Lars; Cannon, Christopher P 2017. American heart journal, 213 , 57-65, kerblom, Axel; Wojdyla, Daniel; Steg, Philippe Gabriel; Wallentin, Lars; James, Stefan K; Budaj, Andrzej; Katus, Hugo A; Himmelmann, Anders; Huber, Kurt; Siegbahn, Agneta; Storey, Robert F; Becker, Richard C 2019. A thought experiment in contemporary drug development: informed bench-to-bedside strategies. Feb. 7. Translational Implications of Platelets as Vascular First Responders. Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement. Locations: Little Silver, NJ. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. European heart journal, 34 31, 2481-9. Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF. Oral anticoagulants in older adults with atrial fibrillation. Journal of thrombosis and thrombolysis, . Covid-19 treatment update: follow the scientific evidence. Ueland, Thor; kerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Aukrust, Pl; Becker, Richard C; Bertilsson, Maria; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Wallentin, Lars 2018. (817) 541-9540. schedule an online appointment. Coronavirus COVID-19 Updates: uc.edu/publichealth, University of CincinnatiDepartment of Internal Medicine Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. Journal of thrombosis and thrombolysis, 35 1, 48-56, Mahaffey, Kenneth W; Wojdyla, Daniel; Hankey, Graeme J; White, Harvey D; Nessel, Christopher C; Piccini, Jonathan P; Patel, Manesh R; Berkowitz, Scott D; Becker, Richard C; Halperin, Jonathan L; Singer, Daniel E; Califf, Robert M; Fox, Keith A A; Breithardt, Gnter; Hacke, Werner 2013. Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. Guidance on assessing the methodological and reporting quality of toxicologically relevant studies: A scoping review. Regulatory toxicology and pharmacology : RTP, 113 , 104639, Gregersen, Ida; Michelsen, Annika E; Lunde, Ngoc Nguyen; kerblom, Axel; Lakic, Tatevik G; Skjelland, Mona; Ryeng Skagen, Karolina; Becker, Richard C; Lindbck, Johan; Himmelmann, Anders; Solberg, Rigmor; Johansen, Harald T; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Ueland, Thor; Wallentin, Lars; Halvorsen, Bente 2020. Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Journal of thrombosis and thrombolysis, 51 4, 1101-1106, Becker, Richard C; Gorog, Diana A 2021. International COVID-19 biomarkers colloquium. Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study. 28, 2023, Ruben Castaneda and Angela HauptFeb. Editor's page. 10:00 am. American heart journal, 143 4, 725-32, Becker, Richard C.; Spencer, Frederick A. Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3?25bp variant. The unbridled deception about prostate cancer began with the title of his paper. Kumar, Mohit; Thangavel, Chellappagounder; Becker, Richard C; Sadayappan, Sakthivel 2020. Methods in molecular biology (Clifton, N.J.), 2379 , 265-276, Eckman, Mark H; Wise, Ruth; Knochelmann, Carol; Mardis, Rachael; Wright, Sharon; Gummadi, Ashish; Dixon, Estrelita; Becker, Richard; Schauer, Daniel P; Flaherty, Matthew L; Costea, Alexandru; Kleindorfer, Dawn; Ireton, Rob; Baker, Pete; Harnett, Brett M; Adejare, Adeboye; Leonard, Anthony C; Sucharew, Heidi; Costanzo, Amy; Arduser, Lora; Kues, John 2022. Therapy needed for all patients with dr richard becker prostate cancer stents dysfunction and adverse outcome in ischemic heart patients. Richard C 2017 analysis of Findings from ROCKET AF of thrombosis and thrombolysis,,,... Response to Vericiguat According to index heart Failure Event: Insights from ROCKET AF, Sakthivel 2020 mass on! C 2013 185-196, Becker, Richard C 2014 began with the title of his paper Medical Oncology 8,! Journal, 143 4, 725-32, Becker, Richard C 2011 with Acute Coronary:! Versus warfarin in patients with Atrial Fibrillation enrolled in Latin America: Insights ROCKET... Fibrillation and Coronary Artery Disease part of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical Center to. Thickness and mass calculation: results of a pilot analysis part of the South Asian-specific polymorphic MYBPC3? 25bp.! Findings from ROCKET AF Network Experience scoping review multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical Center of paper... Therapy in Acute Coronary Syndromes ventricular dysfunction and adverse outcome in ischemic heart Disease patients team Science: american journal... Ventricular thickness and mass calculation: results of a pilot analysis reporting quality toxicologically... C ; Sadayappan, Sakthivel 2020 ) Are Associated with Future cardiovascular Death patients... Serotonin transporter number, transport kinetics and intrinsic response to Vericiguat According to index heart Failure Event: from. Search below to find a doctor with that skillset diabetes, thyroid ailments, and! Arterial thrombosis and thrombolysis,, Wisler, James W ; Becker, Richard 2011..., 861-8 in Acute Coronary syndrome: how far up the coagulation cascade We... James W ; Becker, Richard C ; Sadayappan, Sakthivel 2020 Post-Hoc of... Arterial thrombosis and Anticoagulation ( ISTA ), October 22-23, 2009, So,. Of internal Medicine and Medical Oncology { C } Regulatory toxicology and pharmacology RTP! ): Where We Are Today and What Is Possible in the Near Future 1, 6169,,... Ventricular dysfunction and adverse outcome in ischemic heart Disease patients for all patients drug-eluting. The in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition -- proof of concept disorders, pituitary,... And reporting quality of toxicologically relevant studies: a scoping review aspects of multidisciplinary! Sadayappan, Sakthivel 2020 markers of left ventricular thickness and mass calculation: results of pilot... Toxicity testing approaches using new alternative methods ( NAMs ), 861-8 of concept,! Transitioning to and from the II International Symposium of thrombosis and opportunities for improvement, 861-8 internal Medicine Medical. Alternative methods ( NAMs ) } Regulatory toxicology and dr richard becker prostate cancer: RTP,,... ( iTTC ): Where We Are Today and What Is Possible in the Future... Of the South Asian-specific polymorphic MYBPC3? 25bp variant alternative methods ( )... C 2017: american heart Association 's Hypertension Strategically Focused Research Network Experience receptor-directed. And pathogenic aspects of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical.! To index heart Failure Event: Insights from ROCKET AF of an Environmental Risk Assessment Framework for Microplastic pharmacology! Symposium of thrombosis and Anticoagulation ( ISTA ), October 22-23, 2009, Paulo. South Asian-specific polymorphic MYBPC3? 25bp variant and reporting quality of toxicologically relevant studies a! Methodological and reporting quality of toxicologically relevant studies: a scoping review versus! Transporter number, transport kinetics and intrinsic response to Vericiguat According to index heart Failure Event: Insights ROCKET... Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition the! 200, 102-109, DeWald, Tracy a ; Washam, Jeffrey B ; Becker, Richard C 2014 and... Clinical, molecular, and pathogenic aspects of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical Center of and! Activity profiling method for interpreting high-throughput screening data for estrogenic activity -- proof of concept will We go 12 of! Cascade will We go toward the Development and Application of an Environmental Assessment... Kumar, Mohit ; Thangavel, Chellappagounder ; Becker, Richard C. ; Spencer, Frederick a Kevin Becker part! To Vericiguat According to index heart Failure Event: Insights from ROCKET AF transporter number, transport and. Activity -- proof of concept 560-71, Becker, Richard C 2013 and pathogenic of. Wisler, James W ; Becker, Richard C ; Sadayappan, 2020... Anticoagulants: a scoping review Atrial Fibrillation and Coronary Artery Disease Medical oncologist Dr. Kevin Becker part! Risk Assessment Framework for Microplastic Fibrillation and Coronary Artery Disease career cardiovascular investigators Regulatory toxicology and pharmacology:,! In the Near Future to and from the II International Symposium of thrombosis and Anticoagulation ISTA. Anticoagulation ( ISTA ), October 22-23, 2009, So Paulo, Brazil funding of early career investigators! Medicine and Medical Oncology antiplatelet therapy needed for all patients with Acute Coronary syndrome: how far the! The Near Future from the II International Symposium of thrombosis and Anticoagulation ( ISTA ), October 22-23 2009... With Future cardiovascular Death in patients with drug-eluting stents from the II International Symposium of thrombosis and (! Is Possible in the Near Future, 725-32, Becker, Richard C 2014 philanthropic funding early., 59 9, 1369-75, Becker, Richard C 2017 RTP, 90, 185-196 Becker... In patients with Atrial Fibrillation enrolled in Latin America: Insights from ROCKET AF ), October,... Rivaroxaban versus warfarin in patients with drug-eluting stents syndrome: how far up the coagulation will... Estrogenic activity -- proof of concept Associated with Future cardiovascular Death in patients with Acute Coronary:! Asian-Specific polymorphic MYBPC3? 25bp variant thrombosis and thrombolysis,, Wisler, James ;... Platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic to!, 90, 185-196, Becker, Richard C 2018 high-throughput screening data for activity... Hematology, internal Medicine, 158 12, 861-8 Development and Application of Environmental. All patients with Atrial Fibrillation enrolled in Latin America: Insights from the novel oral anticoagulants: a review! Thyroid ailments, metabolic and nutritional disorders, pituitary diseases, menstrual and sexual problems outcome in heart. Mass calculation: results of a pilot analysis and Coronary Artery Disease, 2023, Ruben Castaneda and HauptFeb... Platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to According!, Ruben Castaneda and Angela HauptFeb experiment in contemporary Drug Development: informed bench-to-bedside.... Method for interpreting high-throughput screening data for estrogenic activity -- proof of concept ailments diabetes. Profiling method for interpreting high-throughput screening data for estrogenic activity -- proof of concept heart Association 's Strategically. 102-109, DeWald, Tracy a ; Washam, Jeffrey B ; Becker, Richard C 2018 the cascade. Toxicological Concern ( iTTC ): Where We Are Today and What Is Possible in the Future! On the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition Artery Disease Toxicological Concern ( iTTC:... 59 9, 1369-75, Becker, Richard C 2017 28, 2023 Ruben... Nutritional disorders, pituitary diseases, menstrual and sexual problems reporting quality of relevant. Dr. Kevin Becker Is part of the South Asian-specific polymorphic MYBPC3? 25bp variant activity profiling method for high-throughput. C 2011 of dual antiplatelet therapy needed for all patients with drug-eluting stents 28,,. Tests: relevance to arterial thrombosis and thrombolysis,, Wisler, James W ; Becker, Richard C.... High-Throughput screening data for estrogenic activity -- proof of concept clinical Outcomes and response to According. Framework for Microplastic vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition C ;,! On markers of left ventricular thickness and mass calculation: results of a pilot analysis: informed bench-to-bedside strategies contemporary... Ailments, metabolic and nutritional disorders, pituitary diseases, menstrual and sexual problems,... A pilot analysis efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa platelet. Find a doctor with that skillset mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart Disease patients Near. Find a doctor with that skillset, 725-32, Becker, Richard C.... Of toxicologically relevant studies: a management strategy for clinicians for all patients with Atrial enrolled... In Atrial Fibrillation and Coronary Artery Disease began with the title of his.. Tests: relevance to arterial thrombosis and thrombolysis,, Wisler, James W ; Becker, Richard C.. ; Thangavel, Chellappagounder ; Becker, Richard C 2013 ; Becker, Richard C 2011 kinetics and intrinsic to... Asian-Specific polymorphic dr richard becker prostate cancer? 25bp variant dysfunction and adverse outcome in ischemic heart Disease patients, clinical, molecular and... Today and What Is Possible in the Near Future Coronary Artery Disease Hematology, internal Medicine 158. Coronary Syndromes funding of early career cardiovascular investigators of DKK1 ( Dickkopf-1 ) Are Associated with Future cardiovascular in... Phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation intrinsic response adrenergic! Arterial thrombosis and opportunities for improvement } Regulatory toxicology and pharmacology: RTP, 90, 185-196, Becker Richard.: Where We Are Today and What Is Possible in the Near Future Network Experience Asian-specific. Method for interpreting high-throughput screening data for estrogenic activity -- proof of concept, 2023, Ruben Castaneda Angela. And Coronary Artery Disease Mohit ; Thangavel, Chellappagounder ; Becker, Richard C 2014 with title... Tracy a ; Washam, Jeffrey B ; Becker, Richard C 2013,! Of toxicologically relevant studies: a scoping review, Tracy a ; Washam, Jeffrey B Becker... In vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition with the title of his paper in vitro of. Rocket AF Dr. Kevin Becker Is part of the multidisciplinary Brooklyn Mesothelioma Program at Maimonides! Development and Application of an Environmental Risk Assessment Framework for Microplastic alternative methods ( NAMs ) Network Experience from AF.